Dymon Asia Capital »

Dianthus Therapeutics shares owned by Dymon Asia Capital

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Dymon Asia Capital from 13F filings

Historical chart of Dymon Asia Capital investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Dymon Asia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Dymon Asia Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $638k 7.6k 83.92

More positions owned by Dymon Asia Capital

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Ishares Tr Mbs Etf (MBB)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Lumentum Hldgs (LITE)
Alibaba Group Hldg Sponsored Ads (BABA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Vaneck Etf Trust Semiconductr Etf (SMH)
Ishares Silver Tr Ishares (SLV)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Msci Sth Afr Etf Call Option (EZA)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
UnitedHealth Call Option (UNH)
Microchip Technology (MCHP)

View all positions for Dymon Asia Capital

Top funds holding Dianthus Therapeutics

FMR
BlackRock
RA Capital Management
Wellington Management Company
Fairmount Funds Management
Avidity Partners Management
Vanguard Group
Vanguard Capital Management
Octagon Capital Advisors
TCG Crossover Management
Citadel Advisors
State Street Corporation
VR Adviser
Fred Alger Management
Deerfield Management Company

View all funds holding Dianthus Therapeutics